The Peter Attia Drive

Podbit · The Peter Attia Drive

#403 ‒ Peptides: separating scientific promise from marketing hype

Explore episode Aug 10, 2026

Where this was said

What FDA approval provides when evaluating peptide safety and effectiveness

At 34:50 · chapter starts 34:45

Peter deliberately sidesteps the politically charged love-it-or-hate-it debate about the FDA and asks instead: what information do you gain, and what do you give up, by choosing a drug that has completed formal development versus one that hasn't? The list of what formal development provides is substantial: defined benefit in a defined population, studied dose and formulation, pharmacokinetic profile, characterized safety and contraindications, known drug interactions, monitoring requirements, and manufacturing standards around identity, potency, purity, sterility, and lot-to-lot consistency. FDA approval doesn't mean a drug is perfect or safe forever — drugs get restricted, relabeled, and pulled post-market, which is part of how a properly monitored system is supposed to work. The SS31 example illustrates the context-dependence of approval: a mitochondrial-targeting peptide might reasonably be approved for Barth syndrome, a severe life-limiting disease, on limited evidence, while the same peptide would face an entirely different risk-benefit calculation for a healthy person seeking performance or longevity benefits. What you lose by sticking to approved drugs is early access and cheaper options; what you gain is the evidence and oversight needed to make a defensible decision.

Similar podbits

Health & Fitness
AI in Healthcare: Where It Helps and Where It Doesn't

Using AI to Increase Your Intelligence & Enrich Humanity | … · Aug 10, 2026 Health & Fitness

AI nailed Andrew Huberman's vertigo-vs-low-blood-pressure diagnosis because that pattern has been reported millions of times. But every patient's liver is different and data on liver surgeries is scarce worldwide — making solo robot surgery dangerous. The rule is simple: data abundance means AI can help; data scarcity means keep the human in the loop.